ID   LST8_HUMAN              Reviewed;         326 AA.
AC   Q9BVC4; B3KMM4; B4DY00; D3DU88; Q5M800; Q86Y18; Q8WUI5; Q9HA66;
AC   Q9UJV6;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   22-JUL-2015, entry version 119.
DE   RecName: Full=Target of rapamycin complex subunit LST8;
DE            Short=TORC subunit LST8;
DE   AltName: Full=G protein beta subunit-like;
DE            Short=Gable;
DE            Short=Protein GbetaL;
DE   AltName: Full=Mammalian lethal with SEC13 protein 8;
DE            Short=mLST8;
GN   Name=MLST8; Synonyms=GBL, LST8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Mao Y., Li Y., Xie Y., Huo K., Hu Q.;
RT   "Cloning and characterization of human LST8 gene.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Embryo, Mammary gland, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph, Placenta, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 97-326 (ISOFORMS 1/2).
RC   TISSUE=Promyelocytic leukemia;
RA   Ramachandiran S., Lau S.S., Monks T.J.;
RT   "A novel G protein beta subunit (G beta 6) in human promyelocytic
RT   leukemia (HL-60) cells.";
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH MTOR AND RPTOR, IDENTIFICATION IN THE TORC1 COMPLEX,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=12408816; DOI=10.1016/S1097-2765(02)00636-6;
RA   Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L.,
RA   Bonenfant D., Oppliger W., Jenoe P., Hall M.N.;
RT   "Two TOR complexes, only one of which is rapamycin sensitive, have
RT   distinct roles in cell growth control.";
RL   Mol. Cell 10:457-468(2002).
RN   [8]
RP   FUNCTION, INTERACTION WITH MTOR, IDENTIFICATION IN THE TORC1 COMPLEX,
RP   MUTAGENESIS OF SER-72; GLY-192 AND PHE-320, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12718876; DOI=10.1016/S1097-2765(03)00114-X;
RA   Kim D.-H., Sarbassov D.D., Ali S.M., Latek R.R., Guntur K.V.P.,
RA   Erdjument-Bromage H., Tempst P., Sabatini D.M.;
RT   "GbetaL, a positive regulator of the rapamycin-sensitive pathway
RT   required for the nutrient-sensitive interaction between raptor and
RT   mTOR.";
RL   Mol. Cell 11:895-904(2003).
RN   [9]
RP   IDENTIFICATION IN THE TORC1 AND TORC2 COMPLEXES.
RX   PubMed=15268862; DOI=10.1016/j.cub.2004.06.054;
RA   Sarbassov D.D., Ali S.M., Kim D.-H., Guertin D.A., Latek R.R.,
RA   Erdjument-Bromage H., Tempst P., Sabatini D.M.;
RT   "Rictor, a novel binding partner of mTOR, defines a rapamycin-
RT   insensitive and raptor-independent pathway that regulates the
RT   cytoskeleton.";
RL   Curr. Biol. 14:1296-1302(2004).
RN   [10]
RP   IDENTIFICATION IN THE TORC2 COMPLEX, AND FUNCTION.
RX   PubMed=15467718; DOI=10.1038/ncb1183;
RA   Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A.,
RA   Hall M.N.;
RT   "Mammalian TOR complex 2 controls the actin cytoskeleton and is
RT   rapamycin insensitive.";
RL   Nat. Cell Biol. 6:1122-1128(2004).
RN   [11]
RP   INTERACTION WITH RHEB.
RX   PubMed=15854902; DOI=10.1016/j.cub.2005.02.053;
RA   Long X., Lin Y., Ortiz-Vega S., Yonezawa K., Avruch J.;
RT   "Rheb binds and regulates the mTOR kinase.";
RL   Curr. Biol. 15:702-713(2005).
RN   [12]
RP   IDENTIFICATION IN THE TORC2 COMPLEX.
RX   PubMed=17461779; DOI=10.1042/BJ20070540;
RA   Pearce L.R., Huang X., Boudeau J., Pawlowski R., Wullschleger S.,
RA   Deak M., Ibrahim A.F.M., Gourlay R., Magnuson M.A., Alessi D.R.;
RT   "Identification of Protor as a novel Rictor-binding component of mTOR
RT   complex-2.";
RL   Biochem. J. 405:513-522(2007).
RN   [13]
RP   IDENTIFICATION IN THE TORC1 AND TORC2 COMPLEXES.
RX   PubMed=17510057; DOI=10.1074/jbc.M702376200;
RA   Wang L., Harris T.E., Roth R.A., Lawrence J.C. Jr.;
RT   "PRAS40 regulates mTORC1 kinase activity by functioning as a direct
RT   inhibitor of substrate binding.";
RL   J. Biol. Chem. 282:20036-20044(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, ACETYLATION [LARGE SCALE
RP   ANALYSIS] AT MET-1 (ISOFORM 3), PHOSPHORYLATION [LARGE SCALE ANALYSIS]
RP   AT SER-7 (ISOFORM 3), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) IN COMPLEX WITH MTOR, WD
RP   REPEATS, AND SUBUNIT.
RX   PubMed=23636326; DOI=10.1038/nature12122;
RA   Yang H., Rudge D.G., Koos J.D., Vaidialingam B., Yang H.J.,
RA   Pavletich N.P.;
RT   "mTOR kinase structure, mechanism and regulation.";
RL   Nature 497:217-223(2013).
CC   -!- FUNCTION: Subunit of both mTORC1 and mTORC2, which regulates cell
CC       growth and survival in response to nutrient and hormonal signals.
CC       mTORC1 is activated in response to growth factors or amino acids.
CC       Growth factor-stimulated mTORC1 activation involves a AKT1-
CC       mediated phosphorylation of TSC1-TSC2, which leads to the
CC       activation of the RHEB GTPase that potently activates the protein
CC       kinase activity of mTORC1. Amino acid-signaling to mTORC1 requires
CC       its relocalization to the lysosomes mediated by the Ragulator
CC       complex and the Rag GTPases. Activated mTORC1 up-regulates protein
CC       synthesis by phosphorylating key regulators of mRNA translation
CC       and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and
CC       releases it from inhibiting the elongation initiation factor 4E
CC       (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389',
CC       which then promotes protein synthesis by phosphorylating PDCD4 and
CC       targeting it for degradation. Within mTORC1, LST8 interacts
CC       directly with MTOR and enhances its kinase activity. In nutrient-
CC       poor conditions, stabilizes the MTOR-RPTOR interaction and favors
CC       RPTOR-mediated inhibition of MTOR activity. mTORC2 is also
CC       activated by growth factors, but seems to be nutrient-insensitive.
CC       mTORC2 seems to function upstream of Rho GTPases to regulate the
CC       actin cytoskeleton, probably by activating one or more Rho-type
CC       guanine nucleotide exchange factors. mTORC2 promotes the serum-
CC       induced formation of stress-fibers or F-actin. mTORC2 plays a
CC       critical role in AKT1 'Ser-473' phosphorylation, which may
CC       facilitate the phosphorylation of the activation loop of AKT1 on
CC       'Thr-308' by PDK1 which is a prerequisite for full activation.
CC       mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2
CC       also modulates the phosphorylation of PRKCA on 'Ser-657'.
CC       {ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:15467718}.
CC   -!- SUBUNIT: Part of the mammalian target of rapamycin complex 1
CC       (mTORC1) which contains MTOR, MLST8, RPTOR, AKT1S1/PRAS40 and
CC       DEPTOR. mTORC1 binds to and is inhibited by FKBP12-rapamycin. Part
CC       of the mammalian target of rapamycin complex 2 (mTORC2) which
CC       contains MTOR, MLST8, PRR5, RICTOR, MAPKAP1 and DEPTOR. Contrary
CC       to mTORC1, mTORC2 does not bind to and is not sensitive to FKBP12-
CC       rapamycin. Interacts directly with MTOR and RPTOR. Interacts with
CC       RHEB. {ECO:0000269|PubMed:12408816, ECO:0000269|PubMed:12718876,
CC       ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718,
CC       ECO:0000269|PubMed:15854902, ECO:0000269|PubMed:17461779,
CC       ECO:0000269|PubMed:17510057, ECO:0000269|PubMed:23636326}.
CC   -!- INTERACTION:
CC       P42345:MTOR; NbExp=4; IntAct=EBI-1387471, EBI-359260;
CC       Q8N122:RPTOR; NbExp=3; IntAct=EBI-1387471, EBI-1567928;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9BVC4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BVC4-3; Sequence=VSP_032665;
CC       Name=3;
CC         IsoId=Q9BVC4-4; Sequence=VSP_032666, VSP_032667, VSP_032668;
CC         Note=Contains a phosphoserine at position 7. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000269|PubMed:19369195};
CC       Name=4;
CC         IsoId=Q9BVC4-5; Sequence=VSP_047368;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in
CC       skeletal muscle, heart and kidney. {ECO:0000269|PubMed:12408816}.
CC   -!- SIMILARITY: Belongs to the WD repeat LST8 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 7 WD repeats. {ECO:0000255|PROSITE-
CC       ProRule:PRU00221}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EAW85539.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY223837; AAO73410.1; -; mRNA.
DR   EMBL; AK021536; BAG51036.1; -; mRNA.
DR   EMBL; AK022227; BAB13990.1; -; mRNA.
DR   EMBL; AK302201; BAG63562.1; -; mRNA.
DR   EMBL; AC009065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85538.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85539.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471112; EAW85541.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85542.1; -; Genomic_DNA.
DR   EMBL; BC001313; AAH01313.1; -; mRNA.
DR   EMBL; BC017119; AAH17119.1; -; mRNA.
DR   EMBL; BC052292; AAH52292.1; -; mRNA.
DR   EMBL; BC088354; AAH88354.1; -; mRNA.
DR   EMBL; AF195883; AAF04308.1; -; mRNA.
DR   CCDS; CCDS10462.2; -. [Q9BVC4-1]
DR   CCDS; CCDS58409.1; -. [Q9BVC4-5]
DR   RefSeq; NP_001186102.1; NM_001199173.1. [Q9BVC4-1]
DR   RefSeq; NP_001186103.1; NM_001199174.1. [Q9BVC4-1]
DR   RefSeq; NP_001186104.1; NM_001199175.1. [Q9BVC4-5]
DR   RefSeq; NP_071767.3; NM_022372.4. [Q9BVC4-1]
DR   UniGene; Hs.29203; -.
DR   PDB; 4JSN; X-ray; 3.20 A; C/D=1-326.
DR   PDB; 4JSP; X-ray; 3.30 A; C/D=1-326.
DR   PDB; 4JSV; X-ray; 3.50 A; C/D=1-326.
DR   PDB; 4JSX; X-ray; 3.50 A; C/D=1-326.
DR   PDB; 4JT5; X-ray; 3.45 A; C/D=1-323.
DR   PDB; 4JT6; X-ray; 3.60 A; C/D=1-326.
DR   PDBsum; 4JSN; -.
DR   PDBsum; 4JSP; -.
DR   PDBsum; 4JSV; -.
DR   PDBsum; 4JSX; -.
DR   PDBsum; 4JT5; -.
DR   PDBsum; 4JT6; -.
DR   ProteinModelPortal; Q9BVC4; -.
DR   SMR; Q9BVC4; 8-324.
DR   BioGrid; 122113; 35.
DR   DIP; DIP-39481N; -.
DR   IntAct; Q9BVC4; 16.
DR   MINT; MINT-3046622; -.
DR   STRING; 9606.ENSP00000380313; -.
DR   PhosphoSite; Q9BVC4; -.
DR   BioMuta; MLST8; -.
DR   DMDM; 74761285; -.
DR   MaxQB; Q9BVC4; -.
DR   PaxDb; Q9BVC4; -.
DR   PRIDE; Q9BVC4; -.
DR   DNASU; 64223; -.
DR   Ensembl; ENST00000382450; ENSP00000371888; ENSG00000167965. [Q9BVC4-5]
DR   Ensembl; ENST00000397124; ENSP00000380313; ENSG00000167965.
DR   Ensembl; ENST00000564088; ENSP00000457870; ENSG00000167965.
DR   Ensembl; ENST00000565250; ENSP00000455046; ENSG00000167965.
DR   Ensembl; ENST00000569417; ENSP00000456405; ENSG00000167965.
DR   GeneID; 64223; -.
DR   KEGG; hsa:64223; -.
DR   UCSC; uc002coy.3; human. [Q9BVC4-1]
DR   CTD; 64223; -.
DR   GeneCards; GC16P002254; -.
DR   H-InvDB; HIX0012725; -.
DR   HGNC; HGNC:24825; MLST8.
DR   HPA; CAB019935; -.
DR   HPA; HPA041841; -.
DR   MIM; 612190; gene.
DR   neXtProt; NX_Q9BVC4; -.
DR   PharmGKB; PA165450213; -.
DR   eggNOG; COG2319; -.
DR   GeneTree; ENSGT00390000014795; -.
DR   HOVERGEN; HBG054763; -.
DR   InParanoid; Q9BVC4; -.
DR   KO; K08266; -.
DR   OMA; AGHHTVK; -.
DR   PhylomeDB; Q9BVC4; -.
DR   TreeFam; TF318577; -.
DR   Reactome; REACT_19358; CD28 dependent PI3K/Akt signaling.
DR   Reactome; REACT_21285; Regulation of AMPK activity via LKB1.
DR   Reactome; REACT_21393; Regulation of Rheb GTPase activity by AMPK.
DR   Reactome; REACT_263991; VEGFR2 mediated vascular permeability.
DR   Reactome; REACT_264164; HSF1-dependent transactivation.
DR   Reactome; REACT_355377; TP53 Regulates Metabolic Genes.
DR   Reactome; REACT_355468; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; REACT_6754; S6K1-mediated signalling.
DR   Reactome; REACT_6836; Release of eIF4E.
DR   Reactome; REACT_6838; mTOR signalling.
DR   Reactome; REACT_75829; PIP3 activates AKT signaling.
DR   SignaLink; Q9BVC4; -.
DR   ChiTaRS; MLST8; human.
DR   GeneWiki; MLST8; -.
DR   GenomeRNAi; 64223; -.
DR   NextBio; 66155; -.
DR   PRO; PR:Q9BVC4; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; Q9BVC4; -.
DR   ExpressionAtlas; Q9BVC4; baseline and differential.
DR   Genevisible; Q9BVC4; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:Reactome.
DR   GO; GO:0034605; P:cellular response to heat; TAS:Reactome.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0043087; P:regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR011047; Quinonprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 3.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Phosphoprotein; Reference proteome; Repeat; WD repeat.
FT   CHAIN         1    326       Target of rapamycin complex subunit LST8.
FT                                /FTId=PRO_0000326499.
FT   REPEAT        1     37       WD 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT       40     80       WD 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT       83    122       WD 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT      126    165       WD 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT      168    207       WD 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT      218    257       WD 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   REPEAT      268    309       WD 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00221,
FT                                ECO:0000269|PubMed:23636326}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:20068231}.
FT   VAR_SEQ       1     66       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_032665.
FT   VAR_SEQ       1      1       M -> MEHAPWSPGASSRARAGHTM (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_032666.
FT   VAR_SEQ      44     44       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_047368.
FT   VAR_SEQ     192    198       GNCYVWN -> APRHLLG (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_032667.
FT   VAR_SEQ     199    326       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_032668.
FT   MUTAGEN      72     72       S->D: Impairs interaction with MTOR.
FT                                {ECO:0000269|PubMed:12718876}.
FT   MUTAGEN     192    192       G->D: Abolishes interaction with MTOR.
FT                                {ECO:0000269|PubMed:12718876}.
FT   MUTAGEN     320    320       F->S: Impairs interaction with MTOR.
FT                                {ECO:0000269|PubMed:12718876}.
FT   CONFLICT     56     56       M -> V (in Ref. 2; BAB13990).
FT                                {ECO:0000305}.
FT   CONFLICT    153    153       H -> Y (in Ref. 5; AAH88354).
FT                                {ECO:0000305}.
FT   CONFLICT    248    248       R -> G (in Ref. 1; AAO73410).
FT                                {ECO:0000305}.
FT   STRAND       10     19       {ECO:0000244|PDB:4JSN}.
FT   STRAND       22     27       {ECO:0000244|PDB:4JSN}.
FT   TURN         29     31       {ECO:0000244|PDB:4JSN}.
FT   STRAND       34     39       {ECO:0000244|PDB:4JSN}.
FT   STRAND       47     50       {ECO:0000244|PDB:4JSN}.
FT   STRAND       54     60       {ECO:0000244|PDB:4JSN}.
FT   STRAND       65     72       {ECO:0000244|PDB:4JSN}.
FT   STRAND       78     81       {ECO:0000244|PDB:4JSN}.
FT   STRAND       86     93       {ECO:0000244|PDB:4JSN}.
FT   STRAND       97    104       {ECO:0000244|PDB:4JSN}.
FT   STRAND      107    113       {ECO:0000244|PDB:4JSN}.
FT   STRAND      122    126       {ECO:0000244|PDB:4JSN}.
FT   STRAND      131    136       {ECO:0000244|PDB:4JSN}.
FT   STRAND      140    147       {ECO:0000244|PDB:4JSN}.
FT   STRAND      152    156       {ECO:0000244|PDB:4JSN}.
FT   TURN        157    159       {ECO:0000244|PDB:4JSN}.
FT   STRAND      162    165       {ECO:0000244|PDB:4JSN}.
FT   STRAND      173    178       {ECO:0000244|PDB:4JSN}.
FT   STRAND      182    189       {ECO:0000244|PDB:4JSN}.
FT   STRAND      194    199       {ECO:0000244|PDB:4JSN}.
FT   HELIX       203    205       {ECO:0000244|PDB:4JSN}.
FT   STRAND      210    216       {ECO:0000244|PDB:4JSN}.
FT   STRAND      223    228       {ECO:0000244|PDB:4JSN}.
FT   STRAND      232    239       {ECO:0000244|PDB:4JSN}.
FT   STRAND      242    248       {ECO:0000244|PDB:4JSN}.
FT   TURN        249    251       {ECO:0000244|PDB:4JSN}.
FT   STRAND      254    259       {ECO:0000244|PDB:4JSN}.
FT   STRAND      263    265       {ECO:0000244|PDB:4JSP}.
FT   STRAND      273    278       {ECO:0000244|PDB:4JSN}.
FT   STRAND      282    289       {ECO:0000244|PDB:4JSN}.
FT   STRAND      292    298       {ECO:0000244|PDB:4JSN}.
FT   TURN        299    301       {ECO:0000244|PDB:4JSN}.
FT   STRAND      304    309       {ECO:0000244|PDB:4JSN}.
FT   STRAND      315    322       {ECO:0000244|PDB:4JSN}.
SQ   SEQUENCE   326 AA;  35876 MW;  43A600D4EF2B6543 CRC64;
     MNTSPGTVGS DPVILATAGY DHTVRFWQAH SGICTRTVQH QDSQVNALEV TPDRSMIAAA
     GYQHIRMYDL NSNNPNPIIS YDGVNKNIAS VGFHEDGRWM YTGGEDCTAR IWDLRSRNLQ
     CQRIFQVNAP INCVCLHPNQ AELIVGDQSG AIHIWDLKTD HNEQLIPEPE VSITSAHIDP
     DASYMAAVNS TGNCYVWNLT GGIGDEVTQL IPKTKIPAHT RYALQCRFSP DSTLLATCSA
     DQTCKIWRTS NFSLMTELSI KSGNPGESSR GWMWGCAFSG DSQYIVTASS DNLARLWCVE
     TGEIKREYGG HQKAVVCLAF NDSVLG
//
